Technology has transformed the way we work, communicate, travel, eat, move, and more. Yet in biopharma, it still takes 12 years to develop a single drug. Even today, thousands of diseases affecting hundreds of millions of people have no effective treatment. Accelerating the pace of bringing effective, new medicines to patients is one of the greatest opportunities for humanity. 

Our mission is to develop better drugs, faster using technology. We have built an end-to-end technology-driven drug discovery platform centered around one of the field’s largest human genomics databases in neuroscience. We use machine learning to map the complex causes of disease and turn those insights into promising drug candidates on our internal biology and chemistry platforms. We are developing drugs to treat some of the biggest medical challenges today: ALS, Parkinson’s Disease, and Alzheimer’s Disease.

We closed our Series C with a syndicate of top tier investors (e.g. BlackRock, Eli Lilly, Merck, Section 32, Threshold Ventures, Y Combinator, etc.). We are a team of engineers, neuroscientists, and drug developers united around an audacious vision: to build the next Genentech of the digital age. 

The Head of Finance will ensure that Verge is appropriately capitalized to achieve our highest long term return on investment (ROI). Partnering with the Leadership Team and future CFO, you have the opportunity to rewrite the standard biotech financing playbook by pioneering creative capital formation strategies for a new breed of tech-enabled drug discovery companies. You will partner to drive external finance and strategy, inform internal resources and capital allocation decisions, and support strategic planning and operational decisions using data-driven analytics. 

Your 12 month outcomes...

• Strategic finance: Acts as a thought partner to the Leadership Team and future CFO on strategic financial questions. Capable of producing executive team and Board-quality presentations. 
• FP&A: internal champion of long range plans, budgets, quarterly forecasts, as well as strategic scenario analyses that inform capital allocation decisions.
• Investor Relations: financial subject matter expert, able to articulate financial roadmap to investors in a clear and compelling way. 
• BD: valued partner to BD team as objective evaluator of external investment decisions by way of traditional NPV analysis and the strategic perspective afforded from scenario analyses.
• Other: trusted business partner and strategic advisor to R&D and platform technology teams.

You will...

• Strategic Finance:
• Develop ad-hoc financial scenario analyses for the CFO in preparation for executive team and meetings of the Verge Board of directors.
• Build discounted cash flow valuation models that estimate the net present value of potential asset acquisitions, collaborations and alliances.
• Develop financial projections to support corporate development activities including fundraising.
• FP&A:
• Lead and develop annual long range plans and budgets and quarterly forecasts.
• Operations:
• Work with the Leadership and Finance team achieve overall OKRs and operational goals including, for example, in the area of operational efficiency or IPO readiness preparation.
• Liaise with Verge business areas such as R&D and platform technology to provide ad-hoc financial decision support.

You have...

• 5-7 years of deep individual FP&A experience with 2 years managing an FP&A group in large pharma (e.g. Biogen, Novartis, Genentech, Alexion / Astra Zeneca, Takeda).
• Experience building forecast models and presenting to management
• Deep alignment with our values 
• A passion for making an impact on patients
• MBA preferred

Help us revolutionize the way drugs are discovered & developed:

The startup nature of Verge Genomics provides multiple growth opportunities into other areas of the company. As one of the early employees at Verge, your work will have a direct impact on the foundation of a groundbreaking new drug development model.